Canadian group to address critical gap in healthcare access
Predictmedix AI Inc. (CSE: PMED | OTC: PMEDF | FRA: 3QP), a leader in artificial intelligence-driven health screening solutions from Toronto, has identified India as the initial launchpad for expanding into the direct-to-consumer market with a mobile solution designed to deliver rapid, non-invasive diabetic screening.
Leveraging the company’s proprietary AI technology, the platform is intended to empower millions with instant access to diabetic risk assessments using only a smartphone, eliminating the need for blood draws, lab visits, or clinical infrastructure http://main.mohfw.gov.in.
By combining advanced facial and biometric analysis with seamless smartphone delivery, the solution brings accessible, affordable, and scalable diabetic screening to some of the most underserved populations across India.
This milestone represents a significant step in Predictmedix AI’s broader vision to reshape global healthcare delivery and accelerate the adoption of AI-enabled, mass-scale preventive health solutions.
“We are addressing a critical gap in healthcare access with a cutting-edge solution that empowers individuals to take control of their health using the device they already own — their mobile phone,” said Dr Rahul Kushwah, COO of Predictmedix AI http://who.int.
“India has over 100 million diabetics and a significant number remain undiagnosed. Our app is designed to bridge that diagnostic divide,” Dr Kushwah said on 2 July.
Key Features:
Instant Diabetic Risk Scoring via smartphone.
AI-driven facial and biometric analysis based on Predictmedix’s proven non-invasive screening platform.
User-friendly design with multilingual support for broad accessibility.
Secure, privacy-compliant data handling, in line with India’s Digital Personal Data Protection (DPDP) Act.
Strategic Significance:
India’s diabetes epidemic is accelerating, with estimates projecting nearly 1 in 3 adults to be diabetic or prediabetic by 2045. Simultaneously, smartphone adoption now exceeds 1.1 billion users — a convergence that creates a once-in-a-generation opportunity for mobile-first, AI-powered health solutions.
Platform is uniquely positioned to:
Capture significant market share in a high-need, high-growth region.
Generate recurring revenue streams through direct-to-consumer and B2B channels.
Align with public health priorities of governments, NGOs, and large employers.
Scale globally with minimal marginal cost, leveraging cloud-based delivery.
Predictmedix AI’s proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. Fiinews.com
